Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2ee8af3f090dc75a14e028483b2e0f6 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-401 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46 |
filingDate |
2010-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_110e1967f3b7b5d888f081fd65d3290a |
publicationDate |
2011-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2011166329-A1 |
titleOfInvention |
Combinations of SAP depleting agents and anti-SAP antibodies |
abstract |
The invention describes the use of an antibody specific for serum amyloid P component, for the treatment or prophylaxis of amyloidosis, and the use of a compound which depletes serum amyloid P component from the circulation in combination with an antibody specific for serum amyloid P component. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9737505-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9873686-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10597385-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9701668-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016081983-A1 |
priorityDate |
2007-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |